A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion | NCT00308477 | Trialant
CompletedInterventionalPhase 1Phase 2Updated Feb 13, 2012
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
ClinicalTrials.gov ID
NCT00308477
Lead Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 1Phase 2
Last Update Posted
Feb 13, 2012Estimated
Brief Summary
This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone for the treatment of macular edema associated with branch retinal vein occlusion.
Macular Degeneration
Macular Edema
Branch Retinal Vein Occlusion
dexamethasone
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Macular edema resulting from branch retinal vein condition
The criteria for visual acuity and macular thickness are met